Schrodinger stock continues to fly under the radar despite their game changing technology.
For years pharmaceutical companies have struggled to develop new drugs. For one thing it takes a long time to bring a drug to market and it’s expensive.
Schrödinger solves this problem by using artificial intelligence and machine learning to:
- Accelerate drug development, and
- Reduce costs
Schrödinger is not some flash in the pan operation. Bill Gates and David Shaw support the technology and together the pair owns 50% of the voting shares.
More importantly, Schrödinger is not yet known outside the pharmaceutical industry. No doubt, a bonus for investors who get in early.
Undeniably, the Covid-19 global pandemic has pushed drug development front and center. According to Statista, $202 billion will pour into research and development by 2022. That’s a lot of money headed to Schrodinger!
Last November Shrodinger inked a deal with Bristol Myers Squibb. The deal included a $55 million up from payment and be eligible for $2.7 billion in milestone payments. Also, the company has agreements with the top 20 pharma companies.
The chart (SDGR – NASDAQ) above reveals the potential of a massive breakout to the upside. Last week’s Gamestop frenzy created a short lived buying opportunity. Nevertheless, the future is bright for long term investors.
Conclusion
So, Schrödinger is a new company doing awesome things. First, they developed a software platform using AI and machine learning. Second, drug deployment is now much faster and cheaper than before. Finally, savvy investors have a chance to get in early.
All this evidence makes it highly likely that Schrödinger stock is on the cusp of exploding higher.
Are you looking for investment ideas? How about free analysis?
If you are, be sure to checkout my Ultimate Portfolio + page. It’s packed full of investing ideas along with technical and fundamental analysis.
DISCLAIMER: Content provided in this article is intended for informational purposes only and should not be construed as legal and/or investment advice and should not be relied upon or acted upon without retaining counsel to provide specific legal and/or investment advice based upon your particular situation, jurisdiction and circumstances. No duties are assumed, intended or created by this communication.
© mikehoganonline.com, All Rights Reserved
